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Only a small area within South Africa (SA) is 
malaria endemic and this is in the north-eastern 
part of KwaZulu-Natal, and in Mpumalanga and 
Limpopo provinces.[1] All cases of malaria in other 
areas of SA are imported, either from malaria-
endemic parts of SA or from further afield. 
A large number of migrants travel to SA for economic, political and 
social reasons. According to the United Nations Refugee Agency, SA 
was the leading worldwide destination country of new asylum seekers 
between 2006 and 2011. Between 2008 and 2012, the SA Department 
of Home Affairs registered 778 600 new asylum applications, with 
Zimbabweans accounting for more than half of these.[2] However, as 
only a proportion of migrants to SA are registered as asylum seekers, 
the true number of migrants is unknown.
Many foreign migrants come from malaria-endemic areas and 
present to SA healthcare services after arrival. Groote Schuur 
Hospital (GSH) in Cape Town is a tertiary hospital serving the 
Western Cape Province, with 975 beds and a busy medical casualty 
department that handles ~40 000 patients/year. 
The aim of this study was to establish the number of malaria 
patients presenting to GSH over the 4-year period between 1 April 
2008 and 31 March 2012, and to describe their demographics, clinical 
outcomes and laboratory findings. 
Methods
Using the laboratory information system at the National Health 
Laboratory Service (NHLS) at the GSH haematology laboratory, 
a database was compiled of all malaria tests performed during the 
4-year study period. A malaria test includes a thick and thin malaria 
smear (using a Giemsa stain) and an immunochromatographic 
(ICT) malaria antigen test (BinaxNOW, Alere, USA). However, 
for our study, only the first smear-positive result was included for 
analysis as this is the gold standard.[3] The ICT results were therefore 
not included. Repeat tests for the same patient were also excluded, 
unless performed >1 month after the initial test, in which case it 
was regarded as a second event. Only patients with smear-positive 
malaria who presented to GSH were included for analysis. Using 
results derived from the laboratory information system, laboratory 
findings were documented and patient medical records were then 
reviewed for data on patient demographics and clinical outcomes. 
The study was approved by the Faculty of Health Sciences Ethics 
Committee, University of Cape Town.
Results
During the 4-year study period, 1 410 malaria tests were performed 
at the NHLS GSH haematology laboratory; 333 tests were smear-
positive and 1 077 -negative. Since GSH NHLS is a referral laboratory 
serving a wide region, including clinics and regional hospitals, only 
134 of the total positive tests involved patients attending GSH. Of 
these, 85% (n=114) were male. The median age of patients was 27 
years (range 2 - 59). Plasmodium falciparum was identified on the 
smear in 96% (n=128) of cases, P. ovale in 3% (n=4) of cases, and in 
two cases identification of the Plasmodium sp. was inconclusive due 
to a very low parasitaemia with only a single ring form identified. The 
median haemoglobin concentration on presentation was 11.9 g/dl 
(range 1.3 - 17.7), the median platelet count was 75 × 109/l (range 13 
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Background. The Western Cape Province of South Africa (SA) is not malaria endemic; however, a considerable number of patients present 
with malaria to our healthcare services.
Objectives. To establish the frequency of patients presenting with malaria at Groote Schuur Hospital (GSH), Cape Town, SA, and to 
describe their demographics, clinical outcomes and laboratory findings. 
Methods. An observational, retrospective, descriptive study was conducted, which included all patients presenting with smear-positive 
malaria to GSH over a 4-year period between 1 April 2008 and 31 March 2012.
Results. During the study period, 134 malaria patients presented to GSH for management; 85% (n=114) were male, median age was 
27 years. Of the total smear-positive tests, 96% (n=128) were Plasmodium falciparum, 3% (n=4) P. ovale, and in 1% (n=2) the species 
was not identified. The number of malaria patients increased markedly, from 6 cases in 2008 to 50 cases in 2012. Of the patients, 48.3% 
(n=57) were from Somalia, 8.5% (n=10) from SA and 29% (n=30) from other African countries. One SA patient acquired transfusion-
transmitted malaria from a pooled platelet product, and the other SA patients had travelled to malaria-endemic areas. The remaining 
cases were from countries outside of Africa, including 13% (n=15) from Bangladesh. Almost two-thirds (62%; n=72) were admitted 
to hospital with a median length of stay of 3 days (range 1 - 32). Clinical outcomes were good with only one death and the remaining 
patients being discharged.
Conclusion. Imported malaria is imposing a significant burden on health resources. The costs of medical care for the emergency treatment 
of foreign nationals needs to be recognised, and adequately budgeted for.
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- 275), and the median total white cell count 
was 6.06 × 109/l (range 1.4 - 34) (Table 1). 
A total of 118 medical folders were 
retrieved; 48.3% (n=57) of patients originated 
from Somalia, 8.5% (n=10) from SA, 29% 
(n=30) from other countries in Africa, 
and 15.5% (n=18) came from countries 
outside Africa – mostly Bangladesh (n=15; 
13%) (Fig. 1). Of the SA patients, all had 
travelled to malaria-endemic areas apart 
from one patient who acquired malaria 
via a transfusion of platelet concentrate 
received while an inpatient at GSH. During 
the first year of study, six patients with 
malaria presented to GSH. This increased 
sharply to 24 cases in the second year and 54 
and 50 cases in the third and fourth years, 
respectively (Fig. 2). Of the total, 38.5% 
(n=45) were managed as outpatients and 
62% (n=72) were admitted to hospital wards. 
One patient refused admission. One death 
occurred in a patient with P. falciparum 
complicated by cerebral malaria. The 
remainder were discharged. The median 
hospital stay was 3 days (range 1 - 32). Of the 
total patients for whom folders were found, 
38% (n=44) had liver dysfunction, 11% 
(n=13) had renal dysfunction, and 5% (n=6) 
had documented cerebral malaria (Table 2). 
Discussion 
Our study findings demonstrate a marked 
increase in patients presenting with malaria 
to GSH during the 4-year study period 
between 2008 and 2012. This is in contrast to 
malaria-endemic regions of SA where cases 
of malaria are showing a downward trend. [1] 
Of the study patients, 91.5% came from 
countries outside SA, which is in keeping 
with the pattern of increasing migration 
into this country and into the Western Cape 
Province. The findings are similar to those 
of a recent study on children with sickle 
cell disease presenting to Red Cross War 
Memorial Children’s Hospital, Cape Town, 
which demonstrated an increase in new 
patients over a 10-year period and found that 
93% of the patients originated from African 
countries outside SA.[4] These findings should 
therefore be regarded as an indicator of the 
increased migrant population presenting to 
SA healthcare services across all fields of 
medicine. 
The commonest country of origin of 
malaria patients in our study group was 
Somalia (48% of patients). A significant 
proportion came from Bangladesh (13%), 
having travelled via other countries in 
Africa. Two-thirds of patients required 
hospital admission, the mean length of 
admission being 3 days. One SA patient 
acquired transfusion-transmitted malaria 
from a pooled platelet product. Transfusion-
transmitted malaria is an exceedingly rare 
occurrence. Since 1985, the Western Province 
Blood Transfusion Service has confirmed 
three cases of transfusion-associated malaria, 
two from red cell concentrates and one from 
pooled platelets. The transfusion donors of 
these three cases were found to have very 
low levels of parasitaemia, to have previously 
lived in malaria-endemic areas and to be 
clinically asymptomatic. 
The clinical outcomes in this study group 
were good with only one death (<1% of 
all patients). This low mortality is a likely 
reflection of the semi-immunity of the 
majority of our patients who came from 
malaria-endemic areas.[5] This is in contrast 
Table 1. Haematology and parasitology results
On presentation, median (range)
Haemoglobin (g/dl) 11.9 (1.3 - 17.7)
Platelet count (× 109/l) 75 (13 - 275)
White cell count (× 109/l) 6.06 (1.4 - 34)
Species identified by microscopy, n (%) (N=134)
Plasmodium falciparum 128 (96)
Plasmodium ovale 4 (3)
Inconclusive* 2 (1)
* In each of these cases a single ring form was seen; therefore the parasitaemia was too low to conclusively identify the 
Plasmodium sp. 
Table 2. Demographics and clinical outcomes
Malaria patients (male), % (N=134) 85
Age (years), median (range) 27 (2 - 59) 
Clinical outcomes, n (%)*
Admitted to ward 72 (62)
Liver dysfunction 44 (38)
Renal dysfunction 13 (11)
Cerebral malaria 6 (5)
Outpatient management 45 (38)
Deaths 1 (<1)
Duration of admission (days), median (range) 3 (1 - 32)
*A total of 118 medical folders were retrieved. One patient refused admission. 
10%
8.5%
13%
48%
8.5%
Somalia
Bangladesh
South Africa
Malawi
Mozambique
Democratic Republic of the Congo
Other countries in Africa
Other countries outside Africa
Not recorded in notes
Fig 1. Distribution of malaria patients by country of origin.
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to non-malaria immune patients who 
are known to have a higher mortality if 
contracting malaria following travel to an 
endemic area.[6] 
Rapid testing for malaria species using 
ICT rapid diagnostic tests that detect parasite 
antigen using a dipstick format are now 
widely available. ICT tests are particularly 
useful in remote areas where microscopy is 
unavailable or where laboratory personnel 
are inexperienced in the interpretation of 
smear findings. ICT tests are also quick and 
easy to perform at the point of care, however, 
they have drawbacks particularly in terms of 
sensitivity. The BinaxNOW ICT test used 
at GSH NHLS is known to have a high 
sensitivity for the diagnosis of P. falciparum, 
but is less sensitive for non-P. falciparum 
malaria.[7] Thin and thick smear blood film 
preparations therefore remain the ‘gold 
standard’ for malaria diagnosis and a first 
thin and/or thick smear-positive test was 
used to determine inclusion in this study. 
P. falciparum, the commonest malaria 
species in Africa and also the commonest 
species causing death in Africa, was the 
species identified in the vast majority of 
cases. [8] Most patients were mildly anaemic 
with a median haemoglobin of 11.9 g/dl 
(reference range for males 13 - 17), and had 
moderate thrombocytopenia with a median 
platelet count of 75 × 109/l (reference range 
for males 137 - 373). The mechanism 
for thrombocytopenia in malaria is not 
yet elucidated fully, but a component of 
malarial antigen-associated platelet immune 
destruction has been demonstrated to occur 
in some cases.[9] The median white cell count 
was low-normal at 6.06 × 109/l (reference 
range 4 - 10), reflecting that malaria does not 
typically evoke an inflammatory response 
with an associated neutrophil leucocytosis.
The tertiary healthcare services in Cape 
Town are seeing increased numbers of 
patients with imported malaria who have 
originated from countries outside SA. 
This may be regarded as an indicator of 
the changing demographics of patients 
presenting to the SA healthcare services, 
including to the general medical, surgical 
and obstetric sectors. This growing trend 
is imposing a significant burden on 
healthcare services, which are already under 
strain. This issue needs to be addressed 
in a constructive manner. We recommend 
that a formal budget allocation be made by 
the Department of Health for emergency 
healthcare of foreign migrants. 
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Fig. 2. Frequency of malaria at Groote Schuur Hospital over the 4-year study period (N=134). 
